Business Context and Reporting Period
Company: Community Health Systems, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: April 1, 2015
Event Date: March 31, 2015
Context: The registrant entered into a material definitive agreement to amend its existing accounts receivable securitization program (the "Receivables Facility").
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or general liquidity metrics. It specifically addresses the following debt facility details:
- Facility Type: Accounts Receivable Securitization Program.
- Maximum Borrowing Capacity: Up to $700 million outstanding from time to time, based on eligible receivables.
- Revised Termination Date: Extended to March 21, 2017.
- Administrative Agent: Crédit Agricole Corporate and Investment Bank.
- Managing Agents: The Bank of Nova Scotia and The Bank of Tokyo-Mitsubishi UFJ, Ltd.
Material Changes Versus Prior Period
On March 31, 2015, the company executed a Fourth Omnibus Amendment to its Receivables Facility. The primary material changes include:
- Extension: The scheduled termination date of the facility was extended.
- Amendments: Certain other provisions of the Receivables Sale Agreement, Receivables Purchase and Contribution Agreement, and Receivables Loan Agreement were amended.
- Structure: The facility continues to operate through the sale of healthcare accounts receivable (excluding self-pay) to a special purpose entity (CHS Receivables Funding, LLC) in exchange for cash and/or equity, which are then pledged to lenders.
Guidance, Outlook, Risks, and Contingencies
Management Commentary: The filing confirms the intent for transactions to be treated as "true sales" or absolute contributions. CHS has guaranteed the performance of the Collection Agent but explicitly disclaims responsibility for receivables uncollectible due to the insolvency or bankruptcy of the obligor.
Risks and Termination Events: The Loan Agreement contains customary termination events that could trigger early termination, including:
- Failure to make timely payments or deposits.
- Breach of covenants.
- Failure to make timely payments under other indebtedness.
- Certain changes of control.
- Failure to meet specific leverage ratios and Receivables ratios.
Costs: The company is obligated to pay interest on outstanding loans, upfront fees to managing agents, and ongoing usage fees to committed lenders.
Investor Verification Checklist
- Verify the specific terms of the "certain other provisions" amended in the Fourth Omnibus Amendment (Exhibit 10.1).
- Confirm the current utilization rate of the $700 million facility and the volume of eligible receivables.
- Review the specific leverage and Receivables ratios required to maintain the facility.
- Assess the impact of the extended maturity date (March 2017) on the company's long-term liquidity strategy.